Clinical Pharmacist Approach towards Effectiveness of Pulmonary Rehabilitation of the Patient with COPD: A Randomized Controlled Study

ABSTRACT

Background: COPD is characterized by chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible. Pulmonary rehabilitation is widely accepted as a best result outcome treatment for COPD patients. Clinical pharmacist play a very important role in patient prescription analysis, promoting the Quality of life, patient education, in developing the drug regimen, sensitivity and allergic condition of the patient to the drugs, finding out any ADRs.Objectives: To compare and assess the impact of pharmacist approach on Health related quality of Life of COPD patients undergoing pulmonary rehabilitation at two different time point.Results: Total 112 patients were screened as per study criteria, 70 were recruited and randomized into control and intervention groups of 35 each, respectively. Compared to baseline QOL score, it was improved at the follow-up in intervention group. Out of 35 subjects 33 subjects has shown good and very good QOL (94.28%). All the domains of QOL were improved compared to control group at the follow-up. Highest improved domain was physical health domain among all (difference 25.83) and lowest was socio-economic domain (difference 12.14) Mean total score of quality of life at follow-up has the significant difference 18.1 (p<0.0001).Conclusion: This study elaborated that quality of life of patients with COPD undergoing pulmonary rehabilitation was improved after the clinical pharmacists approach when compared to only standard treatment (control group).

KEYWORDS

• COPD
• Pulmonary rehabilitation
• Collaborative approach
• Pharmacist’s
• intervention
• Pharmaceutical care
• Quality of life

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.55.1s.65Copy

Copyright and licence

© 2021 Author(s)

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 55, ISSUE 1S (SUPPLEMENT)Bioactive Compound Bisacurone in the Turmeric Extract (Turcuron) Prevents Non-alcoholic Fatty Liver Disease by Reduction of LipogenesisKuluvar Gouthamchandra, Heggar Venkataramana Sudeep, Amritha Raj, Illuri Ramanaih, Chandrappa Siddappa, Kodimule Shyamprasad · pp. S48-S55Original ArticleSame type: Article
• Article · VOLUME 55, ISSUE 1S (SUPPLEMENT)Solubility Enhancement of Oxcarbazepine by Melt Sonocrystallization Technique to Increase the BioavailabilityVinayak Shivamurthy Mastiholimath, Gauri Pradeep Mashelkar, Vinodkumar Shirshalappa Mannur, Panchaxari Mallappa Dandagi, Pukar Khanal · pp. S56-S65Original ArticleSame type: Article
• Article · VOLUME 55, ISSUE 1S (SUPPLEMENT)Transdermal Delivery of Fluconazole ß-cyclodextrin Complex Incorporated in Aloe vera Gel for Fungal Therapy: Development, Characterization and in vitro EvaluationDeepak Aswal, Tanuja Bisht · pp. S66-S74Original ArticleSame type: Article
• Article · VOLUME 55, ISSUE 1S (SUPPLEMENT)Preparation, Characterization and Optimization of Repurposed Valproic Acid Loaded Carboxymethyl Chitosan Nanoparticles by Box–Behnken Design for Alzheimer ManagementAyush Jaiswal, Senthil Venkatachalam, Anindita De, Bhavesh Namdev, Ravikumar Ramaswamy, Jawahar Natarajan · pp. S75-S86Original ArticleSame type: Article